Press Releases Blue Water Ventures International, Inc.

Equities

BWVI

US09609E1055

Market Closed - OTC Markets Other stock markets 03:02:26 2024-07-05 pm EDT			5-day change	1st Jan Change
0.0015 ^USD	0.00%		+15.38%	-97.58%

Jun. 20	Blue Water Ventures International, Inc. announced that it expects to receive $10 million in funding	CI
2023	Psycheceutical Bioscience, Inc. Announces Chief Executive Officer Changes	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Veru Sells ENTADFI Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones	23-04-21	AQ
Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review	23-04-13	PR
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab	23-03-29	GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	23-03-21	GL
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	23-03-21	AQ
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	23-02-15	GL
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	23-02-15	AQ
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	23-02-02	GL
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	23-02-02	AQ
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	23-01-26	GL
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	23-01-26	AQ
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	23-01-10	GL
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	23-01-10	AQ
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	22-11-29	GL
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	22-11-29	AQ
Mannatech is Reinventing Hydration Introduces Exclusive Blue Water	22-11-07	AQ
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	22-10-18	GL
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	22-10-18	AQ
Kevin Harrington, Original Shark from Shark Tank and Futurist Zappy Zapolin to Open Wonderland 2022	22-10-05	NE
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council	22-10-04	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Blue Water Ventures International, Inc.

Equities

BWVI

US09609E1055

Press Releases

Filters